Lack of Evidence Does Not Equal Lack of Benefit: Neoadjuvant Chemotherapy and Trimodality Therapy in Selected Patients with Muscle-Invasive Bladder Cancer : In response to: Dirk Böhmer and Arne Grün. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer.

Di Maria Jiang Peter Chung Girish S Kulkarni Nick D James Srikala S Sridhar

Curr Oncol Rep

Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Center, University Health Network, University of Toronto, 700 University Avenue, Toronto, Ontario, M5G 6M9, Canada.

Published: March 2021

Download full-text PDF	Source
http://dx.doi.org/10.1007/s11912-021-01035-9	DOI Listing

Publication Analysis

Top Keywords

neoadjuvant chemotherapy

muscle-invasive bladder

bladder cancer

lack evidence

evidence equal

equal lack

lack benefit

benefit neoadjuvant

chemotherapy trimodality

trimodality therapy

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?